Biosimilarity The FDA Perspective von Niazi, Sarfaraz Khan 1949-

URL des Erstveröffentlichers

Prescrizione off-label normative e applicazioni von Caputi, Achille Patrizio

DE-1046
DE-1047
Volltext

Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account von Osmane, Malik

DE-1046
DE-1047

Biosimilars design and analysis of follow-on biologics von Chow, Shein-Chung 1955-

DE-91

The generic challenge understanding patents, FDA and pharmaceutical life-cycle management von Voet, Martin A.